In brief
As the Democratic Republic of Congo implements a vaccination program against mpox, reports indicate a significant reduction in new infections, with daily cases dropping from dozens to just a few. However, experts caution against complacency, noting ongoing transmission, particularly among children.
The Democratic Republic of Congo (DR Congo) is experiencing a notable decline in mpox cases, according to medical professionals at the Lwiro clinic in the eastern province of South Kivu. Previously overwhelmed by the outbreak, the clinic reports that they are now seeing only two or three new mpox cases daily after the introduction of a vaccination campaign. The World Health Organization (WHO) has confirmed that the country is witnessing a "plateauing" of new cases, although health experts emphasize the need for sustained vigilance.Before the vaccination effort began, the clinic had been inundated with mpox patients, with long queues and healthcare providers struggling to manage the crisis. Nurse Emmanuel Fikiri expressed relief at the recent improvements, attributing it to high vaccine uptake among the community. Since receiving 265,000 vaccine doses from international donors, over 50,000 individuals have been vaccinated, focusing on the populations most at risk.Despite the positive trends, Dr. Jean Kaseya of the Africa Centres for Disease Control (Africa CDC) raised alarms about the disproportionate impact of mpox on children, who still remain unvaccinated. Currently, an estimated 30% of those infected with mpox in DR Congo are children. This situation is further complicated as the WHO has recently approved a vaccine for children, which may help in curtailing the spread among younger individuals.Health professionals like Jackson Murhula are cautiously optimistic, noting the recent decline in patient intake; however, they emphasize that it is too early to declare victory over the epidemic. The Lwiro clinic’s experience illustrates a shift in community behavior, with more patients seeking medical care as soon as symptoms arise rather than relying solely on traditional healing methods.Despite the progress made, experts like WHO incident manager Dr. Samuel Boland cautioned against complacency. The DR Congo still accounts for a significant proportion of mpox cases globally, and the situation remains precarious, especially as neighboring countries also report cases.Ongoing vaccination efforts across Africa, including in Nigeria and Rwanda, are critical. As health authorities continue to bolster vaccination and surveillance systems, hopes remain that by early 2024, there may be further reductions in infections and mortality related to this outbreak. The global community remains vigilant as evidence will guide the assessment of the public health emergency status concerning mpox in the DR Congo and beyond.
